Health policy

Citations 71-80 of 129 total displayed.

Interventional cardiology and surgery
Continued improvement of clinical outcome and cost effectiveness following intravascular ultrasound guided PCI: insights from a prospective, randomised study

A L Gaster, U Slothuus Skjoldborg, J Larsen, L Korsholm, C von Birgelen, S Jensen, P Thayssen, K E Pedersen, and T H Haghfelt
Heart 2003; 89: 1043-1049. [Abstract] [Full text] [PDF] [Request Permissions]  

Scientific letters
Diagnostic accuracy of a new shorter dobutamine infusion protocol in stress echocardiography

J A San Román, A Serrador, J R Ortega, A Medina, and F Fernández-Avilés
Heart 2003; 89: 1089-1090. [Extract] [Full text] [PDF] [Request Permissions]  

Cardiovascular medicine
Clinical utility and cost effectiveness of a personal ultrasound imager for cardiac evaluation during consultation rounds in patients with suspected cardiac disease

E C Vourvouri, L Y Koroleva, F J Ten Cate, D Poldermans, A F L Schinkel, R T van Domburg, W B Vletter, and J R T C Roelandt
Heart 2003; 89: 727-730. [Abstract] [Full text] [PDF] [Request Permissions]  

Editorials
Drug treatment of hypertension: implications of ALLHAT

B Williams
Heart 2003; 89: 589-590. [Extract] [Full text] [PDF] [Request Permissions]  

Education in Heart
A RATIONAL BASIS FOR SELECTION AMONG DRUGS OF THE SAME CLASS

Morris J Brown
Heart 2003; 89: 687-694. [Extract] [Full text] [PDF] [Request Permissions] [ Web-only References ]  

Papers
Question and answer session

Heart 2003; 89: 35ii-37ii. [Extract] [Full text] [PDF] [Request Permissions]  

Education in Heart
Ambulatory blood pressure monitoring in the management of hypertension

Eoin O’Brien
Heart 2003; 89: 571-576. [Extract] [Full text] [PDF] [Request Permissions] [ Web-only References ]  

Editorials
The primacy of clinical effectiveness for cost effectiveness analysis

I P Casserly and E J Topol
Heart 2003; 89: 249-250. [Extract] [Full text] [PDF] [Request Permissions]  

Cardiovascular medicine
Cost effectiveness of extended treatment with low molecular weight heparin (dalteparin) in unstable coronary artery disease: results from the FRISC II trial

M Janzon, L-Å Levin, and E Swahn
Heart 2003; 89: 287-292. [Abstract] [Full text] [PDF] [Request Permissions]  

Education in Heart
DO GUIDELINES INFLUENCE PRACTICE?

Paul W Armstrong
Heart 2003; 89: 349-352. [Extract] [Full text] [PDF] [Request Permissions]